843P Long-term survivors on tebentafusp in phase II trial of previously treated patients with metastatic uveal melanoma
Work
Year: 2022
Type: article
Source: Annals of Oncology
Institutions Thomas Jefferson University Hospital, Oklahoma State University Oklahoma City, University of Oklahoma, Mount Vernon Cancer Centre, Columbia University Irving Medical Center +21 more
Cites:
Cited by: 1
Related to: 10
FWCI: 0.32
Citation percentile (by year/subfield): 44.35
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze